USANA Health Sciences (NYSE:USNA – Get Free Report) is projected to post its quarterly earnings results before the market opens on Tuesday, February 4th. Analysts expect USANA Health Sciences to post earnings of $0.49 per share and revenue of $208,840.00 billion for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.
USANA Health Sciences Stock Performance
NYSE USNA opened at $34.37 on Tuesday. USANA Health Sciences has a one year low of $31.44 and a one year high of $52.75. The company has a market capitalization of $655.04 million, a P/E ratio of 12.14, a P/E/G ratio of 0.92 and a beta of 0.89. The stock has a 50 day moving average price of $36.32 and a 200-day moving average price of $38.33.
Analyst Ratings Changes
Several research analysts recently commented on the company. DA Davidson lifted their price target on USANA Health Sciences from $35.00 to $38.00 and gave the stock a “neutral” rating in a research report on Thursday, January 2nd. StockNews.com raised shares of USANA Health Sciences from a “buy” rating to a “strong-buy” rating in a research note on Saturday, December 28th.
Insider Buying and Selling
In other news, Director Gilbert A. Fuller sold 675 shares of the stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $37.71, for a total value of $25,454.25. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.
About USANA Health Sciences
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Read More
- Five stocks we like better than USANA Health Sciences
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Sizing Up a New Opportunity for NVIDIA Investors
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Is DeepSeek Challenging NVIDIA’s AI Dominance?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- The 3 Biggest M&A Stock Opportunities for 2025
Receive News & Ratings for USANA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.